Cervical Cancer
Reseachers offer review of treatment options for recurrent cervical cancer
Published in Women's Health Weekly, December 15th, 2005
"Treatment for cervical cancer is very successful, especially in early stages. However, most patients presenting in late stages of disease will experience recurrence," acknowledged scientists writing in the journal Best Practice & Research in Clinical Obstetrics & Gynaecology.
G. Dreyer and colleagues stated, "The prognosis of recurrent disease is very poor and treatment options are limited. The diagnosis of recurrence may be apparent or difficult, but determining the extent of disease is always complex. Routine follow-up of asymptomatic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Breast cancer cells are prone to apoptosis and growth arrest after protein silencing - Chlamydia
Male circumcision could reduce Chlamydia trachomatis infection in female partners - Kidney Disease
Study suggests two-thirds of patients with chronic kidney disease go undiagnosed - Sexual & Reproductive Health
Pregnancy achieved in fertile partners of patients after prostate brachytherapy - Women's Health
Researchers advocate extending definition of women's health to include chronic diseases - Apoptosis
Micromolar taxol induced cell necrosis in HeLa cells - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
